Selected article for: "low resistance rate and macrolide resistance high level"

Author: Lee, Mi Suk; Oh, Jee Youn; Kang, Cheol-In; Kim, Eu Suk; Park, Sunghoon; Rhee, Chin Kook; Jung, Ji Ye; Jo, Kyung-Wook; Heo, Eun Young; Park, Dong-Ah; Suh, Gee Young; Kiem, Sungmin
Title: Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia
  • Document date: 2018_6_26
  • ID: sl4u8e6e_170
    Snippet: Generally, it is recommended to use identical antibiotics when switching from intravenous to oral treatment. If the same antibiotics are not available, it is recommended to use antibiotics of the same class. In areas such as the United States where the rate of high-level macrolide resistance is low in S. pneumoniae, oral administration of macrolide is recommended if 1) there are no isolated bacteria or the causative bacteria are S. pneumoniae; an.....
    Document: Generally, it is recommended to use identical antibiotics when switching from intravenous to oral treatment. If the same antibiotics are not available, it is recommended to use antibiotics of the same class. In areas such as the United States where the rate of high-level macrolide resistance is low in S. pneumoniae, oral administration of macrolide is recommended if 1) there are no isolated bacteria or the causative bacteria are S. pneumoniae; and 2) β-lactam and macrolide have been intravenously injected as empirical antibiotics [15] . However, in areas where the rate of high-level macrolide resistance is high in S. pneumoniae such as Korea, there is insufficient evidence to accept these principles as they are. For this reason, it is recommended to use oral antibiotics that are of the same class as that of the starting intravenous antibiotics for a sufficient period.

    Search related documents:
    Co phrase search for related documents
    • causative bacteria and Korea pneumoniae: 1
    • causative bacteria and macrolide resistance: 1
    • empirical antibiotic and high level: 1, 2, 3
    • empirical antibiotic and intravenous antibiotic: 1, 2, 3, 4
    • empirical antibiotic and macrolide resistance: 1
    • empirical antibiotic and oral antibiotic: 1, 2, 3
    • high level and insufficient evidence: 1, 2, 3
    • high level and intravenous switch: 1
    • high level and macrolide resistance: 1
    • high level and oral administration: 1, 2, 3, 4, 5, 6, 7
    • high level and oral antibiotic: 1, 2
    • high level macrolide resistance and macrolide resistance: 1
    • insufficient evidence and oral administration: 1
    • intravenous antibiotic and oral antibiotic: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • intravenous switch and oral administration: 1
    • intravenous switch and oral antibiotic: 1, 2, 3
    • Korea pneumoniae and macrolide resistance: 1, 2